|
🐜
|
Tenascin-C drives persistence of organ fibrosis
15 auth.
S. Bhattacharyya,
Wenxia Wang,
Luisa Morales-Nebreda,
G. Feng,
Minghua Wu,
Xiaodong Zhou,
R. Lafyatis,
J. Lee,
M. Hinchcliff,
C. Feghali-Bostwick,
...
K. Lakota,
G. R. Budinger,
Kirtee Raparia,
Z. Tamaki,
J. Varga
|
7 |
2016 |
7
🐜
|
|
🦁
|
Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?
8 auth.
K. Lakota,
Jun Wei,
M. Carns,
M. Hinchcliff,
J. Lee,
M. Whitfield,
...
S. Sodin‐Šemrl,
J. Varga
|
6 |
2012 |
6
🦁
|
|
🐜
|
Olive Leaf Extract Attenuates Inflammatory Activation and DNA Damage in Human Arterial Endothelial Cells
13 auth.
B. Burja,
T. Kuret,
T. Janko,
Dijana Topalović,
L. Živković,
K. Mrak-Poljšak,
B. Spremo-Potparević,
P. Žigon,
O. Distler,
S. Čučnik,
...
S. Sodin‐Šemrl,
K. Lakota,
M. Frank-Bertoncelj
|
6 |
2019 |
6
🐜
|
|
🐜
|
Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target
17 auth.
R. Marangoni,
Y. Masui,
Feng Fang,
B. Korman,
Gabriel Lord,
Junghwa Lee,
K. Lakota,
Jun Wei,
P. Scherer,
L. Otvos,
...
T. Yamauchi,
N. Kubota,
T. Kadowaki,
Y. Asano,
S. Sato,
W. Tourtellotte,
J. Varga
|
6 |
2017 |
6
🐜
|
|
🐜
|
Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review.
8 auth.
A. Artenjak,
K. Lakota,
Mojca Frank,
S. Čučnik,
B. Rozman,
B. Božič,
...
Y. Shoenfeld,
S. Sodin‐Šemrl
|
5 |
2012 |
5
🐜
|
|
🐜
|
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
11 auth.
T. Yamashita,
K. Lakota,
Takashi Taniguchi,
A. Yoshizaki,
S. Sato,
Wen Hong,
...
Xingchun Zhou,
S. Sodin‐Šemrl,
Feng Fang,
Y. Asano,
J. Varga
|
5 |
2018 |
5
🐜
|
|
🐜
|
Titanium Dioxide Nanotube Arrays for Cardiovascular Stent Applications
9 auth.
I. Junkar,
Mukta Kulkarni,
Metka Benčina,
J. Kovač,
K. Mrak-Poljšak,
K. Lakota,
...
S. Sodin‐Šemrl,
M. Mozetič,
A. Iglič
|
5 |
2020 |
5
🐜
|
|
🦁
|
Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis
9 auth.
K. Lakota,
M. Carns,
Sofia Podlusky,
K. Mrak-Poljšak,
M. Hinchcliff,
J. Lee,
...
M. Tomšič,
S. Sodin‐Šemrl,
J. Varga
|
5 |
2015 |
5
🦁
|
|
🐜
|
Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients
14 auth.
B. Burja,
J. Feichtinger,
K. Lakota,
G. Thallinger,
S. Sodin‐Šemrl,
T. Kuret,
Ž. Rotar,
R. Ješe,
P. Žigon,
S. Čučnik,
...
Polonca Mali,
S. Praprotnik,
M. Tomšič,
A. Hočevar
|
5 |
2018 |
5
🐜
|
